Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy

SIMPLE SUMMARY: Although reduced skeletal muscle mass affects therapeutic efficacy and adverse events in various therapies for hepatocellular carcinoma (HCC), there are no reports on skeletal muscle mass or its changes and prognostic indications in patients with advanced HCC undergoing hepatic arter...

Descripción completa

Detalles Bibliográficos
Autores principales: Oura, Kyoko, Morishita, Asahiro, Tani, Joji, Nomura, Takako, Manabe, Takushi, Takuma, Kei, Nakahara, Mai, Tadokoro, Tomoko, Fujita, Koji, Mimura, Shima, Sanomura, Takayuki, Nishiyama, Yoshihiro, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047018/
https://www.ncbi.nlm.nih.gov/pubmed/36980720
http://dx.doi.org/10.3390/cancers15061834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047018/
https://www.ncbi.nlm.nih.gov/pubmed/36980720
http://dx.doi.org/10.3390/cancers15061834

Ejemplares similares